Piston Bio

Piston Bio is a biotechnology company focused on developing next-generation, off-the-shelf (allogeneic) cell therapies for the treatment of cancer. Founded by industry veterans from Kite Pharma and Sangamo Therapeutics, the company leverages advanced cell engineering techniques to create standardized cell products. These therapies aim to overcome the logistical and cost barriers associated with traditional autologous CAR-T treatments. Piston Bio is headquartered in South San Francisco and is supported by prominent life science investors, including Vida Ventures. The company's mission is to make transformative cell therapies more accessible to a broader patient population. By utilizing a proprietary precision engineering platform, Piston Bio seeks to enhance the persistence and efficacy of engineered immune cells.